Merck & Co., Inc.MRKNYSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank15
Year-over-Year Change
Year-over-year earnings per share growth rate
Latest
-48.71%
↓ 211% vs avg
Percentile
P15
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-15.65%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -48.71% |
| Q3 2025 | 31.07% |
| Q2 2025 | -12.38% |
| Q1 2025 | 36.49% |
| Q4 2024 | 18.40% |
| Q3 2024 | -41.86% |
| Q2 2024 | 14.36% |
| Q1 2024 | 491.67% |
| Q4 2023 | -125.67% |
| Q3 2023 | 179.57% |
| Q2 2023 | -311.71% |
| Q1 2023 | -6.72% |
| Q4 2022 | -7.03% |
| Q3 2022 | -17.95% |
| Q2 2022 | -8.24% |
| Q1 2022 | 14.09% |
| Q4 2021 | -17.68% |
| Q3 2021 | 196.72% |
| Q2 2021 | -51.59% |
| Q1 2021 | 251.81% |
| Q4 2020 | -171.55% |
| Q3 2020 | -2.52% |
| Q2 2020 | -7.03% |
| Q1 2020 | 37.63% |
| Q4 2019 | 24.00% |
| Q3 2019 | -27.88% |
| Q2 2019 | -7.96% |
| Q1 2019 | 61.43% |
| Q4 2018 | -4.11% |
| Q3 2018 | 14.06% |
| Q2 2018 | 137.04% |
| Q1 2018 | 184.38% |
| Q4 2017 | -1460.98% |
| Q3 2017 | -102.89% |
| Q2 2017 | 24.56% |
| Q1 2017 | 32.56% |
| Q4 2016 | -45.57% |
| Q3 2016 | 79.55% |
| Q2 2016 | 7.32% |
| Q1 2016 | 17.14% |